Last updated: 2026-09-05 13:20:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
ABBVIE INC. (ABBV) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $256.34, with a market capitalization of $459.82B and a P/E ratio of 72.05. Over the past 52 weeks, its price has ranged from $190.75 to $267.47. This page covers its latest market performance, valuation, price trends and company information.
$459.82B | |
$257.96 | |
$267.47 | |
$33.33 | |
$260.21 | |
3.05M | |
6.38M | |
72.05 | |
$267.47 | |
$190.75 | |
2.64% | |
-- |
ABBVIE INC. (ABBV) last closed at $260.21 as of 2026-09-04 23:52:52, unchanged from the previous close of $260.21.
During the latest regular trading session, ABBV traded between $33.33 and $267.47, with a volume of 3.05M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, ABBVIE INC. (ABBV) moved from $258.15 to $256.34, representing a decline of 0.70% ($1.81).
The stock traded between $252.33 and $264.25 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 4.00 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 85.5%
ABBV is currently trading at $256.34, placing it 85.5% of the way from its 52-week low of $190.75 to its 52-week high of $267.47. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 57000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of ABBVIE INC. (ABBV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.